Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.19% | $144.12M | $402.37B | 55.26% | 81 Outperform | |
| AstraZeneca | 1.05% | $128.10M | £219.33B | 32.26% | 78 Outperform | |
| Roche Holding AG | 1.02% | $123.95M | CHF250.44B | 37.22% | 73 Outperform | |
| Shell (UK) | 0.95% | $115.81M | £158.50B | 8.75% | 74 Outperform | |
| Nestlé SA | 0.94% | $114.07M | CHF201.13B | 13.34% | 71 Outperform | |
| HSBC Holdings | 0.93% | $113.23M | £182.81B | 45.51% | 79 Outperform | |
| Royal Bank Of Canada | 0.86% | $104.65M | $215.33B | 22.29% | 75 Outperform | |
| Sony | 0.77% | $93.18M | ¥27.65T | 39.80% | 73 Outperform | |
| SAP SE | 0.76% | $92.82M | €241.24B | -6.40% | 66 Neutral | |
| Novartis | 0.70% | $85.31M | $248.86B | 24.38% | 80 Outperform |